These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33947209)

  • 21. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).
    Wahlgren N; Ahmed N; Eriksson N; Aichner F; Bluhmki E; Dávalos A; Erilä T; Ford GA; Grond M; Hacke W; Hennerici MG; Kaste M; Köhrmann M; Larrue V; Lees KR; Machnig T; Roine RO; Toni D; Vanhooren G;
    Stroke; 2008 Dec; 39(12):3316-22. PubMed ID: 18927461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial.
    Bluhmki E; Chamorro A; Dávalos A; Machnig T; Sauce C; Wahlgren N; Wardlaw J; Hacke W
    Lancet Neurol; 2009 Dec; 8(12):1095-102. PubMed ID: 19850525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline National Institutes of Health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke.
    Muchada M; Rubiera M; Rodriguez-Luna D; Pagola J; Flores A; Kallas J; Sanjuan E; Meler P; Alvarez-Sabin J; Ribo M; Molina CA
    Stroke; 2014 Apr; 45(4):1059-63. PubMed ID: 24603070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
    Dong Y; Han Y; Shen H; Wang Y; Ma F; Li H; Wang Y; Dong Q
    Stroke Vasc Neurol; 2020 Dec; 5(4):348-352. PubMed ID: 32611728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Different Dosages of Alteplase in Atrial Fibrillation-Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan.
    Lin SF; Chen CF; Hu HH; Ho BL; Chen CH; Chan L; Lin HJ; Sun Y; Lin YY; Chen PL; Lin SK; Wei CY; Lin YT; Lee JT; Chao AC;
    J Am Heart Assoc; 2022 Feb; 11(3):e023032. PubMed ID: 35048714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.
    Chen X; Delcourt C; Sun L; Zhou Z; Yoshimura S; You S; Malavera A; Torii-Yoshimura T; Carcel C; Arima H; Hackett ML; Robinson T; Song L; Wang X; Lindley RI; Chalmers J; Anderson CS;
    Cerebrovasc Dis; 2020; 49(4):427-436. PubMed ID: 32702699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Mild and Rapidly Improving Stroke Study (MaRISS): Rationale and design.
    Romano JG; Gardener H; Campo-Bustillo I; Khan Y; Riley N; Tai S; Sacco RL; Khatri P; Smith EE; Schwamm LH
    Int J Stroke; 2019 Dec; 14(9):983-986. PubMed ID: 31496438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of Collaterals is Associated with Larger Infarct Volume and Worse Outcome in Patients with Large Vessel Occlusion and Mild Symptoms.
    Kimmel ER; Al Kasab S; Harvey JB; Bathla G; Ortega-Gutierrez S; Toth G; Jaksich EM; Sheharyar A; Roa J; Hasan DM; Samaniego EA
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1987-1992. PubMed ID: 31036341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes and safety profile of Tenecteplase in wake-up stroke.
    Ahmed HK; Logallo N; Thomassen L; Novotny V; Mathisen SM; Kurz MW
    Acta Neurol Scand; 2020 Nov; 142(5):475-479. PubMed ID: 32511749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo.
    Agarwal S; Scher E; Lord A; Frontera J; Ishida K; Torres J; Rostanski S; Mistry E; Mac Grory B; Cutting S; Burton T; Silver B; Liberman AL; Lerario MP; Furie K; Grotta J; Khatri P; Saver J; Yaghi S
    Stroke; 2020 Apr; 51(4):1226-1230. PubMed ID: 32102629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Who will benefit more from low-dose alteplase in acute ischemic stroke?
    Wang X; Lee KJ; Moullaali TJ; Kim BJ; Li Q; Bae HJ; Carcel C; Delcourt C; Arima H; Sato S; Robinson TG; Song L; Chen G; Yang J; Chalmers J; Anderson CS; Lindley R; Woodward M;
    Int J Stroke; 2020 Jan; 15(1):39-45. PubMed ID: 31226920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous tissue plasminogen activator for patients with minor ischemic stroke.
    Huisa BN; Raman R; Neil W; Ernstrom K; Hemmen TM
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):732-6. PubMed ID: 21531576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
    Gusev EI; Martynov MY; Nikonov AA; Shamalov NA; Semenov MP; Gerasimets EA; Yarovaya EB; Semenov AM; Archakov AI; Markin SS;
    Lancet Neurol; 2021 Sep; 20(9):721-728. PubMed ID: 34418399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Occlusion Site on the Safety and Efficacy of Intravenous Alteplase Before Endovascular Thrombectomy: A Prespecified Subgroup Analysis of DIRECT-MT.
    Zhou Y; Xing P; Li Z; Zhang X; Zhang L; Zhang Y; Zhang Y; Hong B; Xu Y; Huang Q; Li Q; Zhao K; Zou C; Yu Y; Zuo Q; Liu S; Zhang L; Majoie CBLM; Roos YBWEM; Treurniet KM; Ye X; Peng Y; Yang P; Liu J;
    Stroke; 2022 Jan; 53(1):7-16. PubMed ID: 34915738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiographic Characteristics of Mild Ischemic Stroke Patients With Visible Intracranial Occlusion: The INTERRSeCT Study.
    Lau HL; Gardener H; Coutts SB; Saini V; Field TS; Dowlatshahi D; Smith EE; Hill MD; Romano JG; Demchuk AM; Menon BK; Asdaghi N
    Stroke; 2022 Mar; 53(3):913-920. PubMed ID: 34753303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
    Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
    Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of alteplase versus aspirin plus clopidogrel in acute minor stroke.
    Lan L; Rong X; Shen Q; Gong H; Li X; Wang H; Li M; Pan J; Zhang X; Peng Y
    Int J Neurosci; 2020 Sep; 130(9):857-864. PubMed ID: 31928267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.